IBM and the University of Oxford used generative AI to find four potential COVID-19 antiviral drugs. The researchers hope this study shows how AI can expedite t
Generative AI May Accelerate Drug Discovery for COVID Antivirals
healthitanalytics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthitanalytics.com Daily Mail and Mail on Sunday newspapers.
The potential of generative AI to accelerate antiviral development and drug discovery
phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.
IBM and Moderna announced a new partnership today to explore the potential of generative AI and quantum computing.
RESEARCH TRIANGLE PARK – IBM scientists have utilized artificial intelligence to help speed up development of molecules for potential use in new “novel antibiotics” that are needed as the spread of antibiotic resistance grows and the need for new drugs increases.
In a blog post and a paper published in Nature Biomedical Engineering, the IBM team said the system would help pace the way to “accelerated discovery.”
“[O]ur IBM Research team has developed an AI system that can help speed up the design of molecules for novel antibiotics. And it works,” wrote Aleksandra Mojsilovic and Payel Das in the blog.